2006
DOI: 10.1016/j.biomaterials.2006.07.008
|View full text |Cite
|
Sign up to set email alerts
|

Stem cell-based tissue engineering with silk biomaterials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
637
0
8

Year Published

2012
2012
2023
2023

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 869 publications
(649 citation statements)
references
References 259 publications
4
637
0
8
Order By: Relevance
“…When the stabilization data presented here are combined with the remarkable mechanical features and tunable release kinetics characteristic of silk carriers (30,43,44), a robust stabilization and delivery platform for antibiotics can be envisioned, extending even to microneedle formats (30). In total, these findings suggest a new path towards eliminating the cold chain, providing new venues towards improved processing, distribution and use of labile therapeutics such as antibiotics and vaccines.…”
Section: Discussionmentioning
confidence: 83%
“…When the stabilization data presented here are combined with the remarkable mechanical features and tunable release kinetics characteristic of silk carriers (30,43,44), a robust stabilization and delivery platform for antibiotics can be envisioned, extending even to microneedle formats (30). In total, these findings suggest a new path towards eliminating the cold chain, providing new venues towards improved processing, distribution and use of labile therapeutics such as antibiotics and vaccines.…”
Section: Discussionmentioning
confidence: 83%
“…The ability of Spidrex to promote a more tenocytic morphology and support tenocyte cell growth is perhaps due to the fact that non-mulberry silks, such as those in Spidrex, contain the cell binding RGD tripeptide motif (Arg-GlyAsp) [39][40][41] and are, therefore, more tenocyte compatible, compared with the other materials tested in this study. Both the qualitative and quantitative cytocompatibility results suggest that Spidrex would pass the in vitro cytotoxicity tests required for medical implant regulatory bodies.…”
Section: Figmentioning
confidence: 97%
“…[32][33][34] Studies evaluating silk as a biomaterial for tendon regeneration have largely focused on the mulberry B. mori silk or composites of B. mori silk with either synthetic polymers or collagen. 28,29,[35][36][37][38] However, given that non-mulberry silks contain the cell binding RGD tripeptide motif, [39][40][41] and have been shown to support fibroblast-like and bone marrow-derived mesenchymal stem cell growth in vitro, 42,43 non-mulberry silk-derived scaffolds hold much promise as biomaterials for enhancing tendon tissue regeneration. 44 In this study, in vitro assays were used to assess the cytocompatibility and immunogenicity of a novel knitted, nonmulberry silk fibroin scaffold designed for use in tendon tissue regeneration.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…El rechazo ocasional es producto de la contaminación de la fibroína con sericina generado por errores en el proceso de desgomado [17]. Presenta una gran resistencia mecánica a tracción, junto a una gran flexibilidad, es biodegradable, pero a un ritmo más lento que en otros biopolímeros orgánicos, lo que permite una mejor consolidación de los tejidos.…”
Section: Introductionunclassified